Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Elijah E. Cummings Lower Drug Costs Now Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
Mental Health Policy, Renal Care Policy, Drug Pricing (H.R.3, SFC bill PDPRA, Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign
Elijah E. Cummings Lower Drug Costs Now Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
Supply Chain,Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign, Renal Care Policy, Mental Health Policy Issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2021 · second_quarter · RA
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Source: Senate LDA
Elijah E. Cummings Lower Drug Costs Now Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
Medicare Part D Redesign, Drug Pricing (H.R.3, SFC bill PDPRA)
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
PKD (Polycystic Kidney Disease) Awareness, Opioid Package, S. 1850 (Protecting Jessica Grubb's Legacy Act), H.R. 3545 (Overdose Prevention and Patient Safety Act) and Veteran Affairs Issues
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
ADPKD (Autosomal dominant polycystic kidney disease); H.R.6082 OVERDOSE PREVENTION AND PATIENT SAFETY ACT - 42 CFR Part 2 - Federal confidentiality law and regulations; Health Care issuses as it relates to TBI (Traumatic Brain Injuries) Clinical Trials
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
PKD (Polycystic Kidney Disease) Awareness, Opioid Package, S. 1850 (Protecting Jessica Grubb's Legacy Act), H.R. 3545 (Overdose Prevention and Patient Safety Act) and Veteran Affairs Issues
Affordable and Safe Prescription Drug Importation Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA); Veterans Issues
Affordable and Safe Prescription Drug Importation Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA)
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Overdose Prevention and Patient Safety Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Protecting Jessica Grubb's Legacy Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Affordable and Safe Prescription Drug Importation Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA)
Affordable and Safe Prescription Drug Importation Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA); Veterans Issues
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Helping Families in Mental Health Crisis Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
21st Century Cures Act
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
H.R.34 - 21st Century Cures Act.
Mental Health Awareness and Improvement Act of 2015
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Mental Health Reform Act of 2015
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Mental Health Reform Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
Mental Health Reform Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
Climate Change Adapt America Bond Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Climate Change Adapt America Bond Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Climate Change Adapt America Bond Act of 2016
Client: OTSUKA AMERICA PHARMACEUTICAL, INC. · Firm: OTSUKA AMERICA PHARMACEUTICAL, INC.
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2020 · fourth_quarter · Q4
Medicare Part D Redesign, Supply Chain, Drug Pricing, Digital Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2020 · third_quarter · Q3
Medicare Part D Redesign, Kidney Health, Digital Health
Kidney Health, Mental Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2020 · second_quarter · Q2
Kidney Health, Mental Health
Supply Chain,Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign, Renal Care Policy, Mental Health Policy Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2020 · first_quarter · Q1
Mental Health Policy, Renal Care Policy, Drug Pricing (H.R.3, SFC bill PDPRA, Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign
42 CFR Part 2, Kidney Health, Mental Health
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2019 · fourth_quarter · Q4
42 CFR Part 2, Kidney Disease, Mental Health
Medicare Part D Redesign, Drug Pricing (H.R.3, SFC bill PDPRA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2019 · third_quarter · Q3
Medicare Part D, 42 CFR Part 2 (CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS) Polycystic Kidney Disease,Mental Health
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2019 · second_quarter · Q2
Mental Health, 42 CFR Part 2 (CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS) Polycystic Kidney Disease, Mental Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2019 · first_quarter · Q1
Mental Health, 42 CFR Part 2 (CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS) and HIPAA (Health Insurance Portability and Accountability Act of 1996), Polycystic Kidney Disease, Digital Medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · fourth_quarter · Q4
Veterans Affairs Issues (no specific bill #) and Mental Health (no specific bill #)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · third_quarter · Q3
PKD (Polycystic Kidney Disease) Awareness, Opioid Package, S. 1850 (Protecting Jessica Grubb's Legacy Act), H.R. 3545 (Overdose Prevention and Patient Safety Act) and Veteran Affairs Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · second_quarter · Q2
ADPKD (Autosomal dominant polycystic kidney disease); H.R.6082 OVERDOSE PREVENTION AND PATIENT SAFETY ACT - 42 CFR Part 2 - Federal confidentiality law and regulations; Health Care issuses as it relates to TBI (Traumatic Brain Injuries) Clinical Trials
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE, Veterans Affairs, Dept of (VA)
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · first_quarter · 1A
Health care, Digital Health, Mental Health and the value of the MyCite product, Autosomal dominant polycystic kidney disease (ADPKD) education,
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · first_quarter · 1A
Health care, Digital Health, Mental Health and the value of the MyCite product, Autosomal dominant polycystic kidney disease (ADPKD) education,
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2018 · first_quarter · Q1
Health care, Digital Health, Mental Health and the value of the MyCite product, Autosomal dominant polycystic kidney disease (ADPKD) education,
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · 4A
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · 4A
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · 4A
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · 4A
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · Q4
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis Digital Health -
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · fourth_quarter · RA
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · third_quarter · Q3
S.1850 - Protecting Jessica Grubb's Legacy Act, H.R.3545 - Overdose Prevention and Patient Safety Act, and Opioid Crisis
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · second_quarter · Q2
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA); Veterans Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2017 · first_quarter · Q1
S.469 - Affordable and Safe Prescription Drug Importation Act, H.R.1245 - Affordable and Safe Prescription Drug Importation Act, and American Health Care Act (AHCA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · second_quarter · 2A
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · second_quarter · 2A
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · fourth_quarter · Q4
H.R.34 - 21st Century Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · third_quarter · 3A
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · third_quarter · Q3
S.2680: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2016, and Medicare Part B Demonstration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · second_quarter · Q2
S.2860: Mental Health Reform Act of 2016, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · first_quarter · Q1
S.1945: Mental Health Reform Act of 2015, S. 1893: Mental Health Awareness and Improvement Act of 2015, H.R. 2646: Helping Families in Mental Health Crisis Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2016 · first_quarter · RA
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · fourth_quarter · 4T
DEA Scheduling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · fourth_quarter · Q4
DEA Scheduling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · second_quarter · 2A
FDASIA, DEA Scheduling
Digital Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · first_quarter · 1A
CMS Part D proposed rule ASP (Average Sales Price) Listing of long acting injectables - only U.S. Senate
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · third_quarter · Q3
DEA Scheduling
Mental Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · second_quarter · Q2
FDASIA, DEA Scheduling
Digital Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2014 · first_quarter · Q1
CMS Part D proposed rule
Otsuka/IBM partnership
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2013 · fourth_quarter · RA
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2013 · fourth_quarter · Q4
ASP (Average Sales Price) listing of Abilify Maintena
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OTSUKA AMERICA PHARMACEUTICAL, INC. via OTSUKA AMERICA PHARMACEUTICAL, INC.
2013 · fourth_quarter · RR
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapies for Renal patients who have CKD statge 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2
Education on Otsuka as a company Improving the U.S. mental health care delivery system Lack of innovative therapiers for Renal patients who have CKD stage 1 and 2